Cargando…

The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury

The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Boakye, Ellen, El Shahawy, Omar, Obisesan, Olufunmilayo, Dzaye, Omar, Osei, Albert D., Erhabor, John, Uddin, S. M. Iftekhar, Blaha, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576092/
https://www.ncbi.nlm.nih.gov/pubmed/36251673
http://dx.doi.org/10.1371/journal.pone.0276187
_version_ 1784811455731728384
author Boakye, Ellen
El Shahawy, Omar
Obisesan, Olufunmilayo
Dzaye, Omar
Osei, Albert D.
Erhabor, John
Uddin, S. M. Iftekhar
Blaha, Michael J.
author_facet Boakye, Ellen
El Shahawy, Omar
Obisesan, Olufunmilayo
Dzaye, Omar
Osei, Albert D.
Erhabor, John
Uddin, S. M. Iftekhar
Blaha, Michael J.
author_sort Boakye, Ellen
collection PubMed
description The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-containing e-liquids. EVALI case burden varied across states, but it is unclear whether this was associated with state-level cannabis vaping prevalence. We, therefore, used linear regression models to assess the cross-sectional association between state-level cannabis vaping prevalence (obtained from the 2019 behavioral Risk Factor Surveillance System) and EVALI case burden (obtained from the Centers for Disease Control and Prevention) adjusted for state cannabis policies. Cannabis vaping prevalence ranged from 1.14%(95%CI, 0.61%-2.12%) in Wyoming to 3.11%(95%CI, 2.16%-4.44%) in New Hampshire. EVALI cases per million population ranged from 1.90(0.38–3.42) in Oklahoma to 59.10(19.70–96.53) in North Dakota. There was no significant positive association but an inverse association between state cannabis vaping prevalence and EVALI case burden (Coefficient, -18.6; 95%CI, -37.5–0.4; p-value, 0.05). Thus, state-level cannabis vaping prevalence was not positively associated with EVALI prevalence, suggesting that there may not be a simple direct link between state cannabis vaping prevalence and EVALI cases, but rather the relationship is likely more nuanced and possibly reflective of access to informal sources of THC-containing e-cigarettes.
format Online
Article
Text
id pubmed-9576092
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95760922022-10-18 The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury Boakye, Ellen El Shahawy, Omar Obisesan, Olufunmilayo Dzaye, Omar Osei, Albert D. Erhabor, John Uddin, S. M. Iftekhar Blaha, Michael J. PLoS One Research Article The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-containing e-liquids. EVALI case burden varied across states, but it is unclear whether this was associated with state-level cannabis vaping prevalence. We, therefore, used linear regression models to assess the cross-sectional association between state-level cannabis vaping prevalence (obtained from the 2019 behavioral Risk Factor Surveillance System) and EVALI case burden (obtained from the Centers for Disease Control and Prevention) adjusted for state cannabis policies. Cannabis vaping prevalence ranged from 1.14%(95%CI, 0.61%-2.12%) in Wyoming to 3.11%(95%CI, 2.16%-4.44%) in New Hampshire. EVALI cases per million population ranged from 1.90(0.38–3.42) in Oklahoma to 59.10(19.70–96.53) in North Dakota. There was no significant positive association but an inverse association between state cannabis vaping prevalence and EVALI case burden (Coefficient, -18.6; 95%CI, -37.5–0.4; p-value, 0.05). Thus, state-level cannabis vaping prevalence was not positively associated with EVALI prevalence, suggesting that there may not be a simple direct link between state cannabis vaping prevalence and EVALI cases, but rather the relationship is likely more nuanced and possibly reflective of access to informal sources of THC-containing e-cigarettes. Public Library of Science 2022-10-17 /pmc/articles/PMC9576092/ /pubmed/36251673 http://dx.doi.org/10.1371/journal.pone.0276187 Text en © 2022 Boakye et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Boakye, Ellen
El Shahawy, Omar
Obisesan, Olufunmilayo
Dzaye, Omar
Osei, Albert D.
Erhabor, John
Uddin, S. M. Iftekhar
Blaha, Michael J.
The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title_full The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title_fullStr The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title_full_unstemmed The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title_short The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
title_sort inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576092/
https://www.ncbi.nlm.nih.gov/pubmed/36251673
http://dx.doi.org/10.1371/journal.pone.0276187
work_keys_str_mv AT boakyeellen theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT elshahawyomar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT obisesanolufunmilayo theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT dzayeomar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT oseialbertd theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT erhaborjohn theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT uddinsmiftekhar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT blahamichaelj theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT boakyeellen inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT elshahawyomar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT obisesanolufunmilayo inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT dzayeomar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT oseialbertd inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT erhaborjohn inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT uddinsmiftekhar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury
AT blahamichaelj inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury